US and EU reg­u­la­tors be­gin of­fer­ing par­al­lel sci­en­tif­ic ad­vice to gener­ic drug­mak­ers

The FDA and Eu­ro­pean Med­i­cines Agency col­lab­o­rate of­ten and meet reg­u­lar­ly, but the two drug reg­u­la­tors have now an­nounced that for the first time, they will be­gin of­fer­ing par­al­lel sci­en­tif­ic ad­vice for gener­ic drug­mak­ers as part of a pi­lot project.

The par­al­lel ad­vice will be­gin for com­plex gener­ic drugs as part of a vol­un­tary pi­lot project that ex­pands up­on FDA and EMA’s par­al­lel ad­vice for new drugs and bi­o­log­ics.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER